Skip to main content
Caplight Logo









Petrichor Healthcare Capital Management

Petrichor Healthcare Capital Management

New York City, New Yorkpetrichorcap.com

Overview

Petrichor Healthcare Capital Management partners with world-class healthcare managers and businesses to provide customized investment structures and support . The Petrichor team of investment professionals comes from highly-regarded financial institutions including OrbiMed Advisors and Fortress Investment Group . Collectively, the team has completed over 80 investments representing more than $5 billion in invested capital and has held over 30 board seats . Petrichor maintains a deep in-house understanding of healthcare products and services, including scientific, technical, and commercial expertise . This healthcare expertise, together with a breadth of experience investing across sectors, geographies, and capital structures, provides a unique combination to help build successful companies . Petrichor provides structured investments to support the development and commercial growth of innovative biopharmaceuticals, medical technologies, and services poised to transform the healthcare landscape .

Year Founded

2017

AUM

$872.2M

Portfolio Companies

9

Investments

Petrichor Healthcare Capital Management investments
CompanyDateStageLead
Palvella TherapeuticsJan 2023Series DLead
VERO BiotechJan 2023VC RoundLead
CorneaGenOct 2019Series BLead
PersiviaOct 2019Series CLead
LeukocareJun 2021VC RoundLead
Book a demo to see all investments

For institutional investors. Book with your work email.

Key People

Tadd Wessel

Founder, Managing Partner

Michael Beecham

Partner

Patrick Lally

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is Petrichor Healthcare Capital Management based?

Petrichor Healthcare Capital Management is headquartered in New York City, New York, United States.

When was Petrichor Healthcare Capital Management founded?

Petrichor Healthcare Capital Management was founded in 2017.

How many portfolio companies does Petrichor Healthcare Capital Management have?

Petrichor Healthcare Capital Management has 9 portfolio companies in Caplight's dataset.

What are some companies in Petrichor Healthcare Capital Management's portfolio?

Portfolio companies visible on Caplight include Palvella Therapeutics, VERO Biotech, CorneaGen, Persivia, Leukocare.

What was Petrichor Healthcare Capital Management's most recent investment shown here?

Petrichor Healthcare Capital Management's most recent investment in this portfolio sample was in VERO Biotech in 2023.

What sectors does Petrichor Healthcare Capital Management focus on?

Petrichor Healthcare Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.

What company stages does Petrichor Healthcare Capital Management focus on?

Petrichor Healthcare Capital Management typically invests at the Mid stage.

What is Petrichor Healthcare Capital Management's AUM?

Petrichor Healthcare Capital Management's assets under management are estimated between $500.0M and $1.0B.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2017
AUM$872.2M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?